RankingsPricing
  1. JP-listed companies
  2. Pharmarise Holdings Corporation
  3. Financials
  4. Total current assets

Pharmarise Holdings CorporationJP:2796

Market cap
¥6.4B
P/E ratio
22.6x
SummaryFinancialsHistorySegmentsOwnershipWorkforce
Period EndTotal current assets (Million JPY)YoY (%)
May 31, 202513,239-3.63%
May 31, 202413,737+20.80%
May 31, 202311,372+4.54%
May 31, 202210,878+3.15%
May 31, 202110,546-1.22%
May 31, 202010,676+11.20%
May 31, 20199,601+5.25%
May 31, 20189,122+9.10%
May 31, 20178,361-7.84%
May 31, 20169,072+9.86%
May 31, 20158,258-3.50%
May 31, 20148,558

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)